These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1919657)

  • 21. Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases.
    Fountzilas G; Daniilidis J; Kosmidis P; Sridhar KS; Kalogera-Fountzila A; Nicolaou A; Makrantonakis P; Banis K; Dimitriadis A; Sombolos K
    Acta Oncol; 1991; 30(7):831-4. PubMed ID: 1722418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative simultaneous chemoradiotherapy in locally advanced cancer of the oral cavity and oropharynx.
    del Campo JM; Felip E; Giralt J; Raspall G; Bescos S; Casado S; Maldonado X
    Am J Clin Oncol; 1997 Feb; 20(1):97-100. PubMed ID: 9020299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
    Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
    Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate].
    Deitmer T; Urbanitz D
    Laryngol Rhinol Otol (Stuttg); 1986 Jan; 65(1):7-10. PubMed ID: 2419720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
    Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T
    J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
    Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J
    Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.
    Bensadoun RJ; Etienne MC; Dassonville O; Chauvel P; Pivot X; Marcy PY; Prevost B; Coche-Dequeant B; Bourdin S; Vallicioni J; Poissonnet G; Courdi A; Teissier E; Lagrange JL; Thyss A; Santini J; Demard F; Schneider M; Milano G
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):237-45. PubMed ID: 9788400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant therapy for organ preservation in head and neck cancer.
    Urba SG; Wolf GT; Bradford CR; Thornton AF; Eisbruch A; Terrell JE; Carpenter V; Miller T; Tang G; Strawderman M
    Laryngoscope; 2000 Dec; 110(12):2074-80. PubMed ID: 11129024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antineoplastic effectiveness and unwanted side effects of polychemotherapy of extensive oro- and hypopharyngeal cancers--results of a prospective therapy study with 5-FU/cisplatin versus 5-FU/carboplatin].
    Welkoborsky HJ; Bleier R; Wissen-Siegert I
    Laryngorhinootologie; 1992 May; 71(5):261-6. PubMed ID: 1616547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined-modality treatment with induction chemotherapy in locally advanced squamous cell carcinoma of the oral cavity and oropharynx.
    Abele R; Lehmann W; Pipard G; Alberto P
    Recent Results Cancer Res; 1985; 98():142-7. PubMed ID: 4035070
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx.
    Wang HM; Hsueh CT; Wang CS; Chen IH; Liao CT; Tsai MH; Yeh SP; Chang JT
    Anticancer Drugs; 2005 Apr; 16(4):447-53. PubMed ID: 15746582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction chemotherapy in head and neck cancer: results of a phase III trial.
    Mazeron JJ; Martin M; Brun B; Grimard L; Lelièvre G; Vergnes L; Haddad E; Feuilhade F; Piedbois P; Strunski W
    Head Neck; 1992; 14(2):85-91. PubMed ID: 1376306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to preoperative concomitant radiochemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer.
    Dobrowsky W; Dobrowsky E; Strassl H; Braun O; Scheiber V
    Eur J Cancer Clin Oncol; 1989 May; 25(5):845-9. PubMed ID: 2500342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.
    Inhestern J; Oertel K; Stemmann V; Schmalenberg H; Dietz A; Rotter N; Veit J; Görner M; Sudhoff H; Junghanß C; Wittekindt C; Pachmann K; Guntinas-Lichius O
    PLoS One; 2015; 10(7):e0132901. PubMed ID: 26186556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radiochemotherapy concepts in advanced carcinomas of the mouth, oro- and hypopharynx].
    Schmitt G; Schnabel T
    Strahlenther Onkol; 1992 Sep; 168(9):497-501. PubMed ID: 1411922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
    Schuller DE; Grecula JC; Agrawal A; Rhoades CA; Orr DA; Young DC; Malone JP; Merz M
    Cancer; 2002 Jun; 94(12):3169-78. PubMed ID: 12115349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
    Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ
    Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
    Kovács AF; Schiemann M; Turowski B
    J Craniomaxillofac Surg; 2002 Apr; 30(2):112-20. PubMed ID: 12069515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
    Tishler RB; Posner MR; Norris CM; Mahadevan A; Sullivan C; Goguen L; Wirth LJ; Costello R; Case M; Stowell S; Sammartino D; Busse PM; Haddad RI
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1036-44. PubMed ID: 16682134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.